ArticlePaediatric drugs2022

Subgroup Analysis of Crisaborole for Mild-to-Moderate Atopic Dermatitis in Children Aged 2 to < 18 Years.

Thomas A Luger et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.